Genmab A (GMAB) Finished Goods (2023 - 2025)

Genmab A has reported Finished Goods for 3 years, with the latest figure at $13.0 million in Q4 2025.

• For the quarter ending Q4 2025, Finished Goods rose 18.18% year-over-year to $13.0 million; the trailing twelve-month figure through Dec 2025 stood at $13.0 million (up 18.18% YoY), and the FY2025 full-year result was $13.0 million, up 18.18% from the prior year.
• Finished Goods for Q4 2025 stood at $13.0 million, up from $11.0 million in the prior quarter.
• The five-year high for Finished Goods was $13.0 million in Q4 2025, with the low at $9.0 million in Q4 2023.
• Historically, Finished Goods has averaged $11.0 million across 3 years, with a median of $11.0 million in 2024.
• Annual changes were most pronounced in 2024 — Finished Goods grew 22.22% — and 2025, when it gained 18.18%.
• Genmab A's Finished Goods stood at $9.0 million in 2023, then climbed by 22.22% to $11.0 million in 2024, then grew by 18.18% to $13.0 million in 2025.
• The last three Finished Goods figures came in at $13.0 million (Q4 2025), $11.0 million (Q4 2024), and $9.0 million (Q4 2023), per Business Quant data.